Search
for
Sort by
Research 421–450 of 1000+
- Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- 260 Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study
- Real-world evidence in alopecia areata treatment: A narrative review
- Melatonin in Dermatology
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata
- A study of serum prolactin in dermatological diseases in a tertiary care hospital of Assam
- BH02 (P100) Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
- CAQ Corner: Basic concepts of transplant immunology
- Topical calcipotriol mixed with topical steroid versus topical steroid alone in treatment of alopecia areata
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review)
- BI35 A case of dupilumab-induced scalp psoriasis and review of the literature
- Top 10 Facts: Common Hair Loss Causes and Management in Patients
- A perspective on predictive markers of alopecia
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata
- Human Placenta Extract (HPH) Suppresses Inflammatory Responses in TNF-α/IFN-γ-Stimulated HaCaT Cells and a DNCB Atopic Dermatitis (AD)-Like Mouse Model
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Malnutrition and Allergies: Tipping the Immune Balance towards Health
- The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Drug-induced alopecia after dupilumab therapy
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases